- Sales revenue up 22.3% in constant currencies, order intake up 39.3%, underlying EBITDA margin1 up 1.4 percentage points to 30.0%
- Strong demand across all product categories and geographies; additionally fueled by significant equipment orders from China and customer stocking initiatives
- Outlook for 2020 increased and adjusted for expected closing of acquisition of Danaher life science assets and for pandemic-related effects
PR Newswire
AUBAGNE, France, April 21, 2020